Stevanato Group SpA (MEX:STVN N) Days Sales Outstanding : 96.56 (As of Mar. 2025)

View and export this data going back to 2022. Start your Free Trial

What is Stevanato Group SpA Days Sales Outstanding?

Stevanato Group SpA's average Accounts Receivable for the three months ended in Mar. 2025 was MXN6,005 Mil. Stevanato Group SpA's Revenue for the three months ended in Mar. 2025 was MXN5,675 Mil. Hence, Stevanato Group SpA's Days Sales Outstanding for the three months ended in Mar. 2025 was 96.56.

The historical rank and industry rank for Stevanato Group SpA's Days Sales Outstanding or its related term are showing as below:

MEX:STVN N' s Days Sales Outstanding Range Over the Past 10 Years
Min: 65.5 Med: 78.83 Max: 100.87
Current: 82.79

During the past 7 years, Stevanato Group SpA's highest Days Sales Outstanding was 100.87. The lowest was 65.50. And the median was 78.83.

MEX:STVN N's Days Sales Outstanding is ranked worse than
67.53% of 810 companies
in the Medical Devices & Instruments industry
Industry Median: 65.905 vs MEX:STVN N: 82.79

Stevanato Group SpA's Days Sales Outstanding declined from Mar. 2024 (102.58) to Mar. 2025 (96.56).

Stevanato Group SpA Days Sales Outstanding Historical Data

The historical data trend for Stevanato Group SpA's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stevanato Group SpA Days Sales Outstanding Chart

Stevanato Group SpA Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Sales Outstanding

Get a 7-Day Free Trial

65.80

64.59

73.88

90.65

91.20

Stevanato Group SpA Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Days Sales Outstanding	Get a 7-Day Free Trial															102.58	77.18	79.13	77.87	96.56

Competitive Comparison of Stevanato Group SpA's Days Sales Outstanding

For the Medical Instruments & Supplies subindustry, Stevanato Group SpA's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Stevanato Group SpA's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stevanato Group SpA's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Stevanato Group SpA's Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

Stevanato Group SpA Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Stevanato Group SpA's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

	Days Sales Outstanding (A: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (5585.934	+	6463.105)	/	2 )	/	24110.412	*	365
=	6024.5195					/	24110.412	*	365
=	91.20

Stevanato Group SpA's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding (Q: Mar. 2025 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2024 )	+	Accounts Receivable (A: Mar. 2025 ))	/	count )	/	Revenue (A: Mar. 2025 )	*	Days in Period
=	( (6463.105	+	5547.291)	/	2 )	/	5675.127	*	365 / 4
=	6005.198					/	5675.127	*	365 / 4
=	96.56

Stevanato Group SpA (MEX:STVN N) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Stevanato Group SpA Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Stevanato Group SpA's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Stevanato Group SpA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stevanato Group SpA (MEX:STVN N) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

STVN:USA 87N:Germany

Address

Via Molinella 17, Piombino Dese, Padua, ITA, 35017

Website

https://www.stevanatogroup.com

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

Stevanato Group SpA Headlines

No Headlines